top of page

Latest News

I love writing guest articles and collaborating
See appearances for Asa's events and podcasts 

Apr 5, 2024

Guest Article

Asa Waldstein

Q1 2024 warning letter roundup with Asa Waldstein

Dietary supplement consultant Asa Waldstein reviews regulatory trends over the last quarter in his FDA warning letter roundup column.

Q1 2024 warning letter roundup with Asa Waldstein

Feb 27, 2024

Press Mention

Stephen Daniells

Celebrating innovation

The Sports & Active Nutrition Summit also celebrated its three new Start-Up Stars, innovative early-stage companies that are disrupting the sector.

Celebrating innovation

Feb 23, 2024

Interview

Asia Sherman

FTC settles with supplement startup over COVID claims

A multi-year case involving dietary supplement startup PPO Lab, the Federal Trade Commission (FTC) and COVID-19-related health claims has come to a close, culminating in a truce that removes fines and lightens administrative burdens on the defendants.

FTC settles with supplement startup over COVID claims

Feb 15, 2024

Interview

Sarah Burden

Adapting your Business Strategy to the Regulatory Outlook

Adapting your Business Strategy to the Regulatory Outlook

Jan 22, 2024

Interview

Danielle Masterson

What can you say in weight loss claims? Experts weigh in

With what feels like a weight loss medication takeover, many are betting that the GLP-1 receptor agonists will rescue America from its obesity epidemic. So what does this mean for the natural weight loss products?

What can you say in weight loss claims? Experts weigh in

Jan 4, 2024

Interview

Danielle Masterson

New year, same problem: FDA issues tejocote root warning, finding the supplements adulterated with poisonous plant

The supplements labeled as weight loss products appear to be mislabeled as testing revealed the tejocote root was substituted with a potentially deadly plant.

New year, same problem: FDA issues tejocote root warning, finding the supplements adulterated with poisonous plant

Jan 3, 2024

Interview

Asia Sherman

Q&A: Apex Compliance founder talks streamlining supplement regulatory marketing compliance

Apex Compliance entered the dietary supplement space to simplify regulatory compliance by helping companies identify the words and phrases across marketing materials that trigger oversight agencies.

Q&A: Apex Compliance founder talks streamlining supplement regulatory marketing compliance

Jan 2, 2024

Guest Article

Asa Waldstein

Q4 warning letter roundup with Asa Waldstein

In his quarterly FDA warning letter roundup, dietary supplement consultant Asa Waldstein reviews trends over the last quarter and year, and he makes 2024 predictions.

Q4 warning letter roundup with Asa Waldstein

Oct 31, 2023

Interview

Jeff Gelski

Sales soar for probiotic-containing soft drinks

Reporting of a SupplySide West presentation

Sales soar for probiotic-containing soft drinks

Oct 10, 2023

Guest Article

Asa Waldstein

Q3 warning letter roundup with Asa Waldstein

In his quarterly FDA warning letter roundup, dietary supplement consultant Asa Waldstein reviews trends around homeopathic products, claims made in YouTube videos, delta-8 THC, and more.

Q3 warning letter roundup with Asa Waldstein

Aug 9, 2023

Interview

Nutraceutical

New software emerges to help nutrition and dietary supplement companies vet marketing claims

The software, named Apex Compliance, finds risky terms and phrases and suggests alternatives on websites, YouTube videos and in uploaded content

New software emerges to help nutrition and dietary supplement companies vet marketing claims

Aug 8, 2023

Interview

Jennifer Grebow

Regulatory compliance software helps supplement, nutrition, functional food, and cannabis brands vet their marketing claims

Called Apex Compliance, the software detects risky marketing terms and phrases and suggests lower-risk alternatives.

Regulatory compliance software helps supplement, nutrition, functional food, and cannabis brands vet their marketing claims

Jul 13, 2023

Interview

Kelly Teal

FDA targets AK Forte distributor for selling drugs, not supplements

Suprimo Imports still lists for sale products targeted by FDA in a warning letter, raising the question whether the company will face any legal or criminal action.

FDA targets AK Forte distributor for selling drugs, not supplements

Jul 11, 2023

Guest Article

Asa Waldstein

Q2 warning letter roundup with Asa Waldstein

In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.

Q2 warning letter roundup with Asa Waldstein

Jul 6, 2023

Interview

Danielle Masterson

New software makes in-house regulatory expertise accessible

From his humble beginnings using keyboard shortcuts to unleashing the power of AI, regulatory risk master Asa Waldstein details how he developed a tool to identify trigger words.

New software makes in-house regulatory expertise accessible

Apr 26, 2023

Interview

Ten experts reflect on state of U.S. hemp industry

Asa and other industry experts interviewed

Ten experts reflect on state of U.S. hemp industry

Apr 21, 2023

Podcast Interview

Benzinga Cannabis

Cutting-Edge Solutions For Hemp Marketing

In the latest episode of The Hoban Minute, straight from the NOCO 9 trade show in Colorado Springs, Xavier interviews Asa Waldstein, founder of Apex Compliance and principal at Supplement Advisory Group. Xavier gets a first look at Asa’s new compliance tool, Apex, and the two discuss the dire need for marketing claim reviews in the hemp cannabinoid product space and how Apex Compliance is a tool designed specifically to help brands, marketers, consultants, and more navigate the ever-changing regulations around marketing their products.

Cutting-Edge Solutions For Hemp Marketing

Apr 3, 2023

Guest Article

Asa Waldstein

Q1 warning letter roundup with Asa Waldstein

In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.

Q1 warning letter roundup with Asa Waldstein

Mar 15, 2023

Press Mention

AHPA

Asa Waldstein wins AHPA Herbal Hero Award

Asa Waldstein is principal of Supplement Advisory Group, chair of the AHPA Cannabis Committee, and undisputed AHPA superfan – championing the association and contributing to AHPA initiatives every chance he gets. With a background in herbalism, Asa has 20 years of experience developing and implementing compliant marketing and cGMP manufacturing processes, and he is widely respected for his dietary supplement and hemp regulatory expertise and creative outreach. His dedication to supporting the market for safe, high quality dietary supplements and herbal products is outstanding and his commitment to advancing AHPA's efforts is inspiring.

Asa Waldstein is the recipient of the 2023 AHPA Herbal Hero Award.

“When I started studying clinical herbalism in the late 90s and followed my passion for herbs into the supplement industry, I had no idea how much fun and opportunity it would bring me. This award signifies that anything is possible if you follow your passions, work hard, and find a supportive community like AHPA. I have been an AHPA member for almost half of my life, and I attribute much of my professional success to the connections and education from being an active AHPA member. I thank the AHPA community for this prestigious award. It's genuinely one of the pinnacles of my professional career, and I am so thankful!”

-Asa Waldstein

Asa Waldstein wins AHPA Herbal Hero Award

Jan 31, 2023

Interview

Steven Hoffman

Hemp and CBD Industry Responds to FDA’s Announcement on CBD

Asa and other industry leaders interviewed

Hemp and CBD Industry Responds to FDA’s Announcement on CBD
bottom of page